A1 adenosine receptor activation increases adipocyte leptin secretion

Endocrinology

Volumn 141, Issue 4, 2000, Pages 1442-1445

  Rice, A M ^a   Fain, J N ^a   Rivkees, S A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; DIPYRIDAMOLE; LEPTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RECEPTOR DENSITY;

EID: 0034455718     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.4.7423     Document Type: Article

References (49)

1. Clinical review 90: Leptin and clinical medicine: A new piece in the puzzle of obesity
2. Effects of the obese gene product on body weight regulation in ob/ob mice
3. Weight-reducing effects of the plasma protein encoded by the obese gene
4. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
5. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
6. Abnormal splicing of the leptin receptor in diabetic mice
7. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats
8. Monogenic disorders of obesity and body fat distribution
9. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
10. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
11. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
12. Leptin and the regulation of body weight in mammals
13. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
14. Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes
15. Regulation of lipolysis and leptin biosynthesis in rodent adipose tissue by growth hormone
16. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes
17. In vivo and in vitro evidence for the involvement of tumor necrosis factor-α in the induction of leptin by lipopolysaccharide
18. Tumor necrosis factor increases serum leptin levels in humans
19. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP
20. 3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice
21. Isoproterenol and somatostatin decrease plasma leptin in humans: A novel mechanism regulating leptin secretion
22. The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL/6 mice
23. 3-adrenergic-mediated suppression of leptin gene expression in rats
24. s protein-coupled pathway in 3T3-L1 adipocytes
25. Interactions between catecholamines, methyl xanthines and adenosine in regulation of cyclic AMP accumulation in hamster adipocytes
26. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats
27. 6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes
28. Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity
29. Modulators of adenosine uptake, release, and inactivation
30. Adenosine receptors: Protein and gene structure
31. Cloned receptors and cardiovascular responses to adenosine
32. Radioimmunoassay of leptin in human plasma
33. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
34. Cloning of rat obese cDNA and its expression in obese rats
35. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes
36. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat
37. Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats
38. CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: An autoradiographic study
39. 6-cyclopentyl-adenosine in the rat
40. Oral dipyridamole increases plasma adenosine levels in human beings
41. 6-cyclopentyladenosine and 8-cyclopentyltheophylline
42. Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236
43. Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions
44. Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine
45. Insulin and insulin-like growth factor 1 antagonize the stimulation of ob gene expression by dexamethasone in cultured rat adipose tissue
46. Local regulation of lipolysis in adipose tissue by fatty acids, prostaglandins and adenosine
47. Animal model for immune dysfunction associated with adenosine deaminase deficiency